Clinical Orthopaedics and Related Research®

, Volume 473, Issue 6, pp 1913–1919 | Cite as

Experimental Disc Herniation in the Rat Causes Downregulation of Serotonin Receptor 2c in a TNF-dependent Manner

  • Daniel Jonsson
  • Oscar Finskas
  • Yuki Fujioka
  • Anders Ståhlberg
  • Kjell OlmarkerEmail author
Symposium: Current Approaches to the Management of Lumbar Disc Herniation



During recent decades, the knowledge of the pathophysiology of disc herniation and sciatica has drastically improved. What previously was considered a strict biomechanical process is now considered a more complex interaction between leaked nucleus pulposus and the tissue in the spinal canal. An inflammatory reaction, with tumor necrosis factor (TNF) playing an essential role, has been demonstrated. However, the exact mechanisms of the pathophysiology of disc herniation remain unknown.


In this study we use an animal model to investigate (1) if and/or how experimental disc herniation affects gene expression in the early phase (24 hours postsurgery) in the dorsal root ganglion; and (2) if TNF inhibition can reduce any observed changes.


A rat model of disc herniation was used. Twenty rats were evenly divided into four groups: naïve, sham, disc herniation, and disc herniation with TNF inhibition. The dorsal root ganglion of the affected nerve root was harvested 24 hours after surgery and analyzed with a TaqMan Low Density Array® quantitative polymerase chain reaction assay. Gene expression levels in sham were compared with disc herniation to assess question 1 and disc herniation to disc herniation with TNF inhibition to assess question 2.


Experimental disc herniation caused a decrease in the expression of the serotonin receptor 2c gene (p = 0.022). TNF inhibition was found to reduce the observed decrease in expression of serotonin receptor 2c (p = 0.037).


Our results suggest that a decrease in the expression of the serotonin receptor 2c gene may contribute to the pathophysiology of disc herniation. Further research on its involvement is warranted.

Clinical Relevance

This pilot study gives a brief insight into cellular changes that may contribute to the pathophysiology of disc herniation. This knowledge may contribute to the development of more and better treatment options for patients with disc herniation and sciatica.


Dorsal Root Ganglion Nucleus Pulposus Disc Herniation Tumor Necrosis Factor Inhibition Disc Puncture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245–5250.CrossRefPubMedGoogle Scholar
  2. 2.
    Byrod G, Rydevik B, Nordborg C, Olmarker K. Early effects of nucleus pulposus application on spinal nerve root morphology and function. Eur Spine J. 1998;7:445–449.CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344:363–370.CrossRefPubMedGoogle Scholar
  4. 4.
    Finskas O, Blixt A, Fujioka Y, Olmarker K. New, clinically more relevant model for nerve root injury in the rat. Spine. 2013;38:1744–1748.PubMedGoogle Scholar
  5. 5.
    Freeman BJ, Ludbrook GL, Hall S, Cousins M, Mitchell B, Jaros M, Wyand M, Gorman JR. Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation. Spine. 2013;38:1986–1994.CrossRefPubMedGoogle Scholar
  6. 6.
    Jeong CY, Choi JI, Yoon MH. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol. 2004;502:205–211.CrossRefPubMedGoogle Scholar
  7. 7.
    Kato K, Kikuchi S, Konno S, Sekiguchi M. Participation of 5-hydroxytryptamine in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats. Spine. 2008;33:1330–1336.CrossRefPubMedGoogle Scholar
  8. 8.
    Kobayashi H, Kikuchi S, Konno S, Kato K, Sekiguchi M. Interaction of 5-hydroxytryptamine and tumor necrosis factor-alpha to pain-related behavior by nucleus pulposus applied on the nerve root in rats. Spine. 2011;36:210–218.CrossRefPubMedGoogle Scholar
  9. 9.
    Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, Hammond A, Kirkham B, Jarvinen S, Niinimaki J, Veeger N, Haapea M, Torkki M, Tervonen O, Seitsalo S, Hurri H. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine. 2006;31:2759–2766.CrossRefPubMedGoogle Scholar
  10. 10.
    Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, Lind K, Sindelka R, Sjoback R, Sjogreen B, Strombom L, Stahlberg A, Zoric N. The real-time polymerase chain reaction. Mol Aspects Med. 2006;27:95–125.CrossRefPubMedGoogle Scholar
  11. 11.
    11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.CrossRefPubMedGoogle Scholar
  12. 12.
    Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion. Spine. 2004;29:2477–2484.CrossRefPubMedGoogle Scholar
  13. 13.
    Nachemson A, Jonsson E. [Backache and Neck Pain—An Evidence-based Review of Causes, Diagnostics and Treatments] [in Swedish]. Stockholm, Sweden: SBU, Swedish Council on Health Technology Assessment; 2000.Google Scholar
  14. 14.
    Olmarker K, Larsson K. Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine. 1998;23:2538–2544.CrossRefPubMedGoogle Scholar
  15. 15.
    Olmarker K, Nutu M, Storkson R. Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine. 2003;28:1635–1641; discussion 1642PubMedGoogle Scholar
  16. 16.
    Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine. 2001;26:863–869.CrossRefPubMedGoogle Scholar
  17. 17.
    Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine. 1993;18:1425–1432.CrossRefPubMedGoogle Scholar
  18. 18.
    Saito H, Wakai J, Sekiguchi M, Kikuchi S, Konno S. The effect of selective serotonin reuptake inhibitor (SSRI) on pain-related behavior in a rat model of neuropathic pain. Eur Spine J. 2014 Jun 5 [Epub ahead of print].Google Scholar
  19. 19.
    Sasaki M, Obata H, Saito S, Goto F. Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain. Anesth Analg. 2003;96:1072–1078, table of contents.CrossRefPubMedGoogle Scholar
  20. 20.
    Sommer C. Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep. 2006;10:101–106.CrossRefPubMedGoogle Scholar
  21. 21.
    Stahlberg A, Elbing K, Andrade-Garda JM, Sjogreen B, Forootan A, Kubista M. Multiway real-time PCR gene expression profiling in yeast Saccharomyces cerevisiae reveals altered transcriptional response of ADH-genes to glucose stimuli. BMC Genomics. 2008;9:170.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci. 2004;25:613–617.CrossRefPubMedGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2014

Authors and Affiliations

  • Daniel Jonsson
    • 1
  • Oscar Finskas
    • 1
  • Yuki Fujioka
    • 1
    • 2
  • Anders Ståhlberg
    • 3
  • Kjell Olmarker
    • 1
    Email author
  1. 1.Musculoskeletal Research, Department of Medical Chemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska AcademyUniversity of GothenburgGothenburgSweden
  2. 2.Department of Orthopaedic Surgery, Programs for Applied Biomedicine, Graduate School of Biomedical SciencesHiroshima UniversityHiroshimaJapan
  3. 3.Sahlgrenska Cancer Center, Department of Pathology, Sahlgrenska AcademyUniversity of GothenburgGothenburgSweden

Personalised recommendations